Prurigo nodularis in HIV-infected individuals

International Journal of Dermatology

Volumn 37, Issue 6, 1998, Pages 401-409

  Matthews, Shannon N ^a   Cockerell, Clay J ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; ANTIHISTAMINIC AGENT; BENOXAPROFEN; CLOFAZIMINE; CORTICOTROPIN; CYCLOSPORIN; DOXEPIN; ERYTHROMYCIN; ETRETINATE; HYDROXYZINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MENTHOL; PHENOL; PRAMOCAINE; STEROID; THALIDOMIDE;

CLINICAL FEATURE; CRYOSURGERY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; EMOTIONAL STRESS; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE COMPLEX DEPOSITION; INTRALESIONAL DRUG ADMINISTRATION; MALNUTRITION; PATHOPHYSIOLOGY; REVIEW; SKIN NODULE; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; PRURIGO;

EID: 0031747787     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00507.x     Document Type: Review

References (83)

1. Liautaud B, Pape JW, DeHovitz JA, et al. Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 1989; 125: 629-632.
2. Shapiro RS, Samorodin C, Hood A. Pruritus as a presenting sign of acquired immunodeficiency syndrome. J Am Acad Dermatol 1990; 16: 1115-1117.
3. Cockerell CJ. Non-infectious inflammatory skin diseases in HIV-infected individuals. Dermatol Clin 1991; 9: 531-541.
4. Cockerell CJ. The itches of HIV and AIDS. In: Bernhard JD, ed. Itch: Mechanisms and Management of Pruritus. New York: McGraw-Hill, 1994: 281-298.
5. Hyde JN. Prurigo nodularis. In: Hyde JN, Montgomery FH, eds. A Practical Treatise on Diseases of the Skin for the Use of Students and Practitioners, 8th edn. Philadelphia: Lea and Febiger, 1994: 174-175.
6. Rowland Payne CME, Wilkinson JD, McKee PH, et al. Nodular prurigo - a clinicopathological study of 46 patients. Br J Dermatol 1985; 113: 431-439.
7. Rowland Payne CME. Prurigo nodularis. In: Bernhard JD, ed. Itch: Mechanisms and Management of Pruritus. New York: McGraw-Hill, 1994: 103-119.
8. Anzala A, Wambugu P, Bosire M, et al. The rate of development of HIV-1 related illness in women with a known duration of infection. International Conference on AIDS, June 20-23 1990; 6: 143.
9. Wambugu P, Plummer FA, Anzala AO, et al. Clinical manifestations of HIV-1 infection among women working as prostitutes in Nairobi. International Conference on AIDS, June 20-23 1990; 6: 260.
10. Kundu A, Arabinda T, Wade AA, Ilchyshyn AH. Prurigo nodularis in an HIV positive man. Genitour Med 1995; 71: 129-135.
11. Penneys NS. Pruritic papular and follicular eruptions. In: Skin Manifestations of AIDS, 2nd edn. St Louis, Mosby, 1995: 160-170.
12. Arnold HL, Odom RB, James WD. Pruritus and neurocutaneous dermatoses. In: Andrew's Diseases of the Skin, 7th edn. Philadelphia: WB Saunders, 1990: 51-67.
13. Berger T, Huffman C, Thieberg M. Prurigo nodularis and photosensitivity in AIDS: treatment with thalidomide. J Am Acad Dermatol 1995; 33: 837-838.
14. Doyle JA, Connolly SM, Hunziker N, Winkelmann RK. Prurigo nodularis: a reappraisal of the clinical and histologic features. J Cutan Pathol 1979; 6: 392-403.
15. Linhardt PW, Walling AD. Prurigo nodularis. J Fam Pract 1993; 37: 495-498.
16. Shelley WB. Consultations in Dermatology II. Philadelphia: WB Saunders, 1974: 44-49.
17. Lever WF, Schaumberg-Lever G. Histopathology of the Skin, 7th edn. Philadelphia: JB Lippincott, 1990: 155.
18. Bernstein J, Swift R, Soltani K, et al. Antipruritic effect on an opiate antagonist, naloxone hydrochloride. J Invest Dermatol 1982; 78: 82-83.
19. Levy JA. Changing concepts in HIV infection: challenges for the 199o's. Opening Ceremony Address at the 6th Annual International Conference on AIDS, San Francisco, CA, June 20, 1990.
20. Perez G, Peters M, et al. Mast cells, neutrophils, and eosinophils in prurigo nodularis. Arch Dermatol 1993; 129: 861-865.
21. Runne U, Orfanos CE. Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo. Arch Dermatol 1977; 113: 787-791.
22. Feuerman EJ, Sandbank M. Prurigo nodularis: histological and electron microscopical study. Arch Dermatol 1975; 111: 1472-1477.
23. Sandbank M. Cutaneous nerve lesions in prurigo nodularis: electron microscopic study of two patients. J Cutan Pathol 1976; 3: 125-132.
24. Pautrier L. Le nevrome de la lichenification circonscrite nodulaire chronique (lichen ruber obtusus corne prurigo nodularis). Annales de Dermatologie 1934; 7: 897.
25. Cowan MA. Neurohistological changes in prurigo nodularis. Arch Dermatol 1964; 89: 754-758.
26. Harris B, Harris K, Penneys NS. Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis. J Am Acad Dermatol 1992; 26: 56-58.
27. Nahass G, Penneys N. Merkel cells and prurigo nodularis. J Am Acad Dermatol 1994; 31: 86-88.
28. Molina F, Abadia T, Burrows NP, et al. Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis. Br J Dermatol 1992; 127: 344-351.
29. Leiferman KM. A current perspective on the role of eosinophils in dermatologic disease. J Am Acad Dermatol 1991; 24: 1101-1112.
30. Hagermark O. Peripheral and central mediators of itch. Skin Pharmacol 1992; 5: 1-8.
31. Hagermark O, Hokfelt T, Pernow B. Flare and itch induced by substance P in human skin. J Invest Dermatol 1978; 71: 233-235.
32. Tuckett R. Neurophysiology and neuroanatomy of pruritus. In: Bernhard JD, ed. Itch: Mechanisms and Management of Pruritus. New York: McGraw-Hill, 1994: 1-22.
33. Lerner EA. Chemical mediators of itching In: Bernhard JD, ed. Itch: Mechanisms and Management of Pruritus. New York: McGraw-Hill, 1994: 23-25.
34. Matis WL, Lauker RM, Murphy GF. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 1990; 94: 491-495.
35. Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985; 315: 61-63.
36. Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 1988; 90: 399-401.
37. Piotrowski W, Foreman JC. Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol 1986; 114: 37-46.
38. Fjellner B, Hagermark O. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Act Derm Venereol 1981; 61: 241-150.
39. Nordlind K, Libing C, Ahmed AA, et al. Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin. Ann NY Acad Sci 1995; 762: 450-451.
40. Diven DG, Newton RC, Ramsey KM. Heightened cutaneous reactions to mosquito bites in patients with acquired immunodeficiency syndrome receiving zidovudine. Arch Intern Med 1988; 148: 2296.
41. Penneys NS, Nayar JK, Bernstein H, et al. A chronic pruritic eruption in patients with AIDS associated with increased antibody titers to mosquito salivary gland antigens. J Am Acad Dermatol 1989; 21: 421-425.
42. Cockerell CJ, Friedman-Kien A. Cutaneous manifestations of HIV infection. In: Color Atlas of AIDS, 2nd edn. Philadelphia: WB Saunders, 1996: 81-158.
43. Denman ST. A review of pruritus. J Am Acad Dermatol 1986; 14: 375-392.
44. Seeburger J, Anderson-Wilms N, Jacobs R. Lennert's lymphoma presenting as prurigo nodularis. Cutis 1993; 51: 355-358.
45. Shelnitz LS, Paller AS. Hodgkin's disease manifesting as prurigo nodularis. Pediatr Dermatol 1990; 7: 136-139.
46. King CA, Huff FJ, Jorizzo JL. Unilateral neurogenic pruritus: paroxysmal itching associated with central nervous system lesions. Ann Intern Med 1982; 97: 222-223.
47. Scott PV, Fischer HBJ. Spinal opiate analgesia and facial pruritus: a neural theory. Postgrad Med J 1982.; 58: 531-535.
48. Jones EA, Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 1990; 11: 884-887.
49. Marx JL. Brain peptides. Is substance P a transmitter of pain signals? Science 1979; 205: 886-889.
50. 4+ lymphocytopenia associated with chronic pruritic papules. Br J Dermatol 1994; 131: 371-375.
51. Belisto DV, Sanchez MR, Baer RL, et al. Reduced Langerhans cells Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 1279-1282.
52. Harber LC. Photosensitivity Diseases, 2nd edn. Toronto: Marcel Decker, 1989: 46-53.
53. Gad SM, Shannon EJ, Krotoski WA, Hastings RC. Thalidomide induces imbalances in T-lymphocyte subpopulations in the circulating blood of healthy males. Lepr Rev 1985; 56: 35-39.
54. Gunzler V. Thalidomide in human immunodeficiency virus (HIV) patients: a review of safety considerations. Drug Safety 1992; 7: 116-134.
55. Bernal JE, Duran M, Londono F, Umana A. Cellular immune effects of thalidomide in actinic prurigo. Int J Dermatol 1992; 31: 599-600.
56. Hojyo-Tomoka T, Vega-Memije E, et al. Actinic prurigo: an update. Int J Dermatol 1995; 34: 380-384.
57. Miadonna A, Zeggieri E, Tedeschi A, et al. Enhanced basophil releasability in subjects infected with human immunodeficiency virus. Clin Immunol Immunopathol 1990; 54: 237-246.
58. Kanazawa K, Yaoita H, Tochigi H, et al. Association of prurigo with hepatitis C virus infection. Arch Dermatol 1995; 131: 852-853.
59. Hann SK, Cho MY, Park YK. UV treatment of generalized prurigo nodularis. Int J Dermatol 1990; 29: 436-437.
60. Vaatainen N, Hannukesela M, Karvonen J. Local photochemotherapy in nodular prurigo. Acta Derm Venereal (Stockh) 1979; 59: 544-547.
61. Londono F. Thalidomide in the treatment of actinic prurigo. Int J Dermatol 1973; 12: 326-328.
62. Carmichael AJ, Knight A. Thalidomide: a restricted role [letter]. Lancet 1992; 339: 1362.
63. Winkelmann RK, Connolly SM, Doyle JA, Padilha-Goncalves A. Thalidomide treatment of prurigo nodularis. Acta Derm Venereal (Stockh) 1984; 64: 412-417.
64. Johnke H, Zachariae H. Thalidomide treatment of prurigo nodularis. Ugeskrift for Laeger 1993; 155: 3018-3030.
65. Belaube P, Devaux J, Pizzi M, et al. Small bowel deposition of crystals associated with the use of clofazimine (Lamprene) in the treatment of prurigo nodularis. Int J Leprosy 1983; 51: 328.
66. Chapon F, Lechevalier B, Da Silva DC, et al. Neuropathies a la thalidomide. Revue Neurologique 1985; 141: 719-728.
67. Fullerton PM, O'Sullivan DJ. Thalidomide neuropathy: a clinical, electrophysiological, and histological follow-up study. J Neural Neurosurg Psych 1968; 31: 543-551.
68. Krucke W, von Hartrott HH, Schroder JM, et al. Lichtund elektronenmikroskopische Untersuchungen zum Sputstadium der Thalidomid-Polyneuropathie. Fortschritte der Neurologie - Psychiatrie und ihrer Grenzgebiete 1971; 39: 15-50.
69. Wulff CH, Hoyer H, Asboe -Hansen G, et al. Development of polyneuropathy during thalidomide therapy. Br J Dermatol 1985; 112: 475-480.
70. Lagueny A, Rommel A, Vignolly B, et al. Thalidomide neuropathy: an electrophysiologic study. Muscle and Nerve 1986; 9: 837-844.
71. Gutierrez-Rodriguez O, Starusta-Bacal P, Gutierrez-Montes O. Thalidomide-induced neuropathy in rheumatoid arthritis patients. Arthr Rheum 1988; 31: 145-146.
72. Hoyer H, Wulff CH, Asboe-Hansen G, Brodthagen H. Behandling of prurigo nodularis Hyde med talidomide. Ugeskrift for Laeger 1983; 145: 3243-3145.
73. Tupker RA, Coenraads PJ, van der Meer JB. Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol (Stockh) 1992; 72: 463.
74. Lembeck F, Gamse R. Substance P in peripheral sensory processes. In: Porter R, O'Connor M, eds. Substance P in the Nervous System. Ciba Foundation Symposium 91. London: Pitman, 1982: 35-49.
75. Hindson C, Lawlor F, Wacks H. Treatment of nodular prurigo with benoxaprofen. Br J Dermatol 1982; 170: 369.
76. Berth-Jones J, Smith SG, Graham-Brown RAC. Nodular prurigo responds to cyclosporin. Br J Dermatol 1995; 132: 795-799.
77. Stoll DM. Treatment of prurigo nodularis: use of cryosurgery and intralesional steroids plus lidocaine. J Derm Surg Oncol 1983; 9: 922.
78. Waldinger TP, Wong RC, Taylor WR, Voorhees J. Cryotherapy improves prurigo nodularis. Arch Dermatol 1984; 120: 1598-1600.
79. Gip L. Prurigo nodularis (Hyde) treated with Tigason. Dermatologica 1984; 169: 260.
80. Hirschel-Scholz S, Salomon D, Merot Y, Saurat JH. Anetodermic prurigo nodularis (with Pautrier's neuroma) responsive to arotinoic acid. J Am Acad Dermatol 1991; 25(Part 2): 437-442.
81. Meyers LN. Use of occlusive membranes in the treatment of prurigo nodularis. Int J Dermatol 1989; 28: 275-276.
82. Crosnier-Servaye A, Couteaux-Durmont C, Lapiere CM. Evolution favourable de deux "prurigo nodulaire" sous traitement par ACTH synthetique et corticosteroides. Arch Belges Dermatol Syphilol 1971; 4: 413.
83. Lindley RP, Payne CMER. Neural hyperplasia is not a diagnostic prerequisite in nodular prurigo. J Cutan Pathol 1989; 16: 14-18.